Fundraising Fox

Zaneta Odrowaz

Investor

Vice President of Company Creation at Frazier Life Sciences

Palo Alto

About

Zaneta Odrowaz joined Frazier Life Sciences in 2022 as a Vice President focused on company creation, and co-founded Attovia Therapeutics, where she serves as Chief Business Officer. She previously was Senior Director of Corporate Development at Amunix Pharmaceuticals, contributing to its acquisition by Sanofi, and earlier held roles as Chief of Staff at Philips Neuro and Engagement Manager at McKinsey. She holds a Ph.D. in Gene Expression from The University of Manchester and a Master's in Biotechnology from Jagiellonian University, and completed a postdoctoral fellowship at Stanford University.

Invests in

Biotech

Experience

  1. Attovia TherapeuticsChief Business Officercurrent2023 — present
  2. Frazier Life SciencesVP Company Creationcurrent2022 — present
  3. Amunix PharmaceuticalsSenior Director Corporate Development2020 — 2022
  4. Philips NeuroChief Of Staff2018 — 2020Pleasanton, CA
  5. McKinsey & CompanyEngagement Manager2015 — 2018
  6. Oxbridge Biotech RoundtableProject Manager2014 — 2015
  7. Stanford UniversityPostdoctoral Fellow2012 — 2015Stanford, CA

Education

  1. The University of ManchesterDoctor of Philosophy (PhD), Gene expression2007 — 2011
  2. Jagiellonian UniversityMasters, Biotechnology2002 — 2007

Skills & more

Cell11Protein Chemistry8Genomics5Confocal Microscopy3Protein Expression4Fluorescence Microscopy7Cell Biology11Molecular Cloning7Western Blotting6Molecular Biology15Tissue Culture1Microscopy3
+12 moreImmunohistochemistryImmunoprecipitationqPCRTransfectionFlow CytometryCell CultureImmunofluorescenceProtein PurificationStrategyRNA isolationDNART-PCR

Languages English · Italian · Polish

From Zaneta's professional profile.

Same school

Shared employers

Investments

Per the firm's website.

Colleagues at Frazier Life Sciences